Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective Study

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 7, 2008, Pages 807-816

  Porrata, Luis F ^a   Inwards, David J ^a   Ansell, Stephen M ^a   Micallef, Ivana N ^a   Johnston, Patrick B ^a   Gastineau, Dennis A ^a   Litzow, Mark R ^a   Winters, Jeffrey L ^a   Markovic, Svetomir N ^a  

^a Mayo Clinic   (United States)

Author keywords

Absolute lymphocyte count; Autologous stem cell transplantation; Natural killer cells; non Hodgkin lymphoma; Survival

Indexed keywords

CARMUSTINE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MULTIVARIATE ANALYSIS; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PREDICTION; PROSPECTIVE STUDY;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 44649124773     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.04.013     Document Type: Article

References (33)

1. Porrata L.F., and Markovic S.N. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clin Exp Med 4 (2004) 78-85
2. Horowitz M.M., Gale R.P., Sondel A., et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75 (1990) 555-562
3. Pavletic Z.S., Joshi S.S., Pirruccello S.J., et al. Lymphoid reconstitution after allogeneic stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 21 (1998) 33-41
4. Powles R., Singhal S., Treleaven J., et al. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood 91 (1998) 3481-3486
5. Porrata L.F., Litzow M.R., Tefferi A., et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 16 (2002) 1311-1318
6. Porrata L.F., Ingle J.N., Litzow M.R., Geyer S.M., and Markovic S.N. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Bone Marrow Transplant 28 (2001) 865-871
7. Nieto Y., Shpall E.J., McNiece I.K., et al. Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant. Clin Cancer Res 10 (2004) 5076-5086
8. Porrata L.F., Inwards D.J., Micallef I.N., Ansell S.M., Geyer S.M., and Markovic S.N. Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease. Br J Haematol 117 (2002) 629-633
9. Gordan L.N., Sugrue M.W., Lynch J.W., Williams K.D., Khan S.A., and Mored J.S. Correlation of early lymphocyte recovery and progressive-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplant 31 (2003) 1009-1013
10. Porrata L.F., Gertz M.A., Inwards D.J., et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin's lymphoma. Blood 98 (2001) 579-585
11. Kim H., Sohn H.J., Kim S.E., et al. Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma. Bone Marrow Transplant 34 (2004) 43-49
12. Joao C., Porrata L.F., Inwards D.J., et al. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma. Bone Marrow Transplant 37 (2006) 865-871
13. Boulassel M.R., Herr A.L., deB Edwardes M.D., et al. Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders. Hematology 11 (2006) 165-170
14. Kim H., Sohn H.J., Kim S., Lee J.S., Kim W.K., and Suh C. Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplant 37 (2006) 1037-1042
15. Porrata L.F., Gertz M.A., Litzow M.R., et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Clin Cancer Res 11 (2005) 1210-1218
16. Cox C.J., Habermann T.M., Payne B.A., et al. Evaluation of the Coulter Counter model S-Plus IV. Am J Pathol 84 (1985) 297-306
17. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329 (1933) 457-481
18. Katipamula R., Porrata L.F., Gastineau D., et al. Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target. Bone Marrow Transplant 37 (2006) 811-817
19. Cheson B.D., Horning S.J., Coiffier B., et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 17 (1999) 1244-1253
20. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
21. Cox D. Regression models and life tables. J R Stat Soc B 34 (1972) 187-202
22. Guillaume T., Rubinstein D.B., and Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell. Blood 92 (1998) 1471-1490
23. Porrata L.F., Litzow M.R., and Markovic S.N. Immune reconstitution after autologous hematopoietic stem cell transplantation. Mayo Clin Proc 76 (2001) 407-412
24. Talmadge J.E., Reed E., Ino K., et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 19 (1997) 161-172
25. Martinez C, Urbano-Ispizua A, Rovira M, et al. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation. Leukemia Lymphoma. 200;37:535-542.
26. Porrata L.F., Inwards D.J., lacy M.Q., and Markovic S.N. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-α in autologous stem cell transplantation. Bone Marrow Transplant 28 (2001) 673-680
27. Porrata L.F., Litzow M.R., Inwards D.J., et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 33 (2004) 291-298
28. Porrata L.F., Gertz M.A., Geyer S.M., et al. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia 18 (2006) 1085-1092
29. Symeonidis A., Ings S., Rabin N., et al. Patients with multiple myeloma transplanted with lymphocyte-rich peripheral blood autograft have more favorable outcome. Haematologica 92 Suppl 2 (2007) abstract P0-822
30. Hirwase D.K., Hirwase S., Bailey M., et al. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 14 (2008) 116-124
31. Porrata L.F., Litzow M.R., Gastineau D.A., et al. Autologous lymphocyte infusion as an immunotherapeutic strategy in autologous stem cell transplantation. Res Adv Cancer 6 (2006) 1-9
32. Tiwari D., Gao F., Hidalgo J., et al. Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-SCF in non-Hodgkin's lymphoma. Bone Marrow Transplant 40 (2007) 671-675
33. Dupont B., and Hsu K.C. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Curr Opin Immunother 16 (2004) 634-643